Tenaya Therapeutics (TNYA) Total Liabilities (2020 - 2026)

Tenaya Therapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $28.9 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 17.61% year-over-year to $28.9 million in Q1 2026; TTM through Mar 2026 was $28.9 million, a 17.61% increase from a year earlier, with the FY2025 full-year figure at $23.7 million, down 12.66% from the prior year.
• Total Liabilities climbed to $28.9 million in Q1 2026 per TNYA's latest filing, from $23.7 million in the prior quarter.
• Across five years, Total Liabilities topped out at $35.6 million in Q4 2022 and bottomed at $22.1 million in Q3 2025.
• The 5-year median for Total Liabilities is $28.9 million (2026), against an average of $28.4 million.
• Across the five-year window, Total Liabilities climbed 29.83% in 2022 and declined 23.52% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $35.6 million in 2022, then decreased by 12.59% to $31.1 million in 2023, then dropped by 12.88% to $27.1 million in 2024, then declined by 12.66% to $23.7 million in 2025, then increased by 22.09% to $28.9 million in 2026.
• Per Business Quant, the three latest TNYA Total Liabilities figures stand at $28.9 million (Q1 2026), $23.7 million (Q4 2025), and $22.1 million (Q3 2025).